AMAZING meeting… brilliant colleagues, beautiful venue, great social events, and the pervasive sense of humor and humility that makes #fortress so authentic! Thanks for the wonderful and productive time!

New study in nature reports MiNK Therapeutics’s, agenT-797, revitalizes exhausted T cells, engages innate and adaptive immune with clinical signals of survival benefit & reduced risk of secondary infections. Read more: nature.com/articles/s4146… #INKTs

Another historical landmark and so exciting! First TIL (tumor infiltrating lymphocytes) approved for melanoma… now to figure out how to improve activity of TIL for other solid tumors! (Like sarcoma!) John E. Mullinax, MD, FACS

Hello #ASCO24!

#immunotherapy #sarcoma #toTLSornottoTLS #ASCO24 still friends, have no fear! 😂 Florent Petitprez

Damn that’s a pretty waterfall plot- #ASPS anlotinib plus anti PD-L1 TQB2450… combo vs sequential? Need a randomized trial but amazing ORR 79.3%

Really impressive session for #mpnst #asco24 - so much work done but still need new therapies great summary by ⁦Angela Hirbe⁩

Herbert Loong, MBBS, FASCO gives the discussion about giving the right drug to the right patient #asco24 #Sarcoma #tcgt and #GIST

At last for our #EHE patients and providers! ⁦Raj Narayanan⁩ incredible experience over the years with IRE for liver EHE lesions- great to see these impressive results! ⁦The EHE Foundation⁩ link.springer.com/article/10.100…

Great to see this incredible data in print!!

Today kicks off Sarcoma Awareness Month! 🎗️ This month is crucial for raising awareness about sarcoma. Support those affected and drive progress towards better treatments. Get involved through the link below. #SarcomaAwarenessMonth #CureSarcoma #cancer buff.ly/2NtTEXP

CU Cancer Center members Breelyn Wilky, MD 🎗, and Steven Thorpe, MD, FACS, discuss what is sarcoma for #SarcomaAwarenessMonth. Stay tuned for more questions and answers about sarcoma! You also can find information about sarcoma on our webpage here: bit.ly/3RLxO4J

Thrilled to be partnering with Dr Steven Thorpe, our new Chief of Musculoskeletal Oncology in Orthopedics at CU Cancer Center - our #sarcoma patients will benefit so much from his experience and perspectives! #sarcomaawareness

Thrilled to host TGCT Support in Colorado for Day of Learning! Amazing turnout! Thanks to Sydney Stern, PhD, MS The Life Raft Group , our faculty speakers and our sponsors!

Afamicel, TCR targeting MAGEA-4 approved for #synovial sarcoma. A remarkable advancement for our patients, laying the foundation for future efforts in solid tumors. businesswire.com/news/home/2024…

New podcast from my colleague Dr Eduardo Davila ⁦Dr.Davila’s Immunology Lab⁩ which is a great layman’s summary of #TIL therapy! Very excited to be a part of this initiative and can’t wait to see it in patients! ⁦CU Cancer Center⁩ news.cuanschutz.edu/news-stories/b…

This is AMAZING!!!! So grateful from #teamsarcoma CU Cancer Center to support critical research for patients! Thank you John Franklin-Myers Denver Broncos !!! Hope to see you at #racetocuresarcoma denver Sarcoma Foundation of America!!!

Thanks to #esmo24 committee for opportunity to present!! And huge thanks Agenus for the partnership to advance immunotherapy for #sarcomas!